Q4 2024 Clearpoint Neuro Inc Earnings Call
Welcome to ClearPoint Neuro Inc. fourth quarter of full year 2024 conference call (Operator Instructions) As a reminder, this conference call is being recorded. Comments made on this call may include ...
DCGI streamlines drug export approvals, enhances regulatory oversight
In a move aimed at simplifying export procedures and enhancing regulatory efficiency, the Drugs Controller General of India ...
Texas Lawsuit Would Require 'Sex Screening' of Student Athletes
The lawsuit accuses the NCAA of failing to comply with Trump's executive order over its amended transgender eligibility ...
Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a ...
On this episode of Fortune’s Leadership Next podcast, co-hosts Diane Brady, executive editorial director of the Fortune CEO ...